Insights into optimal basal insulin titration in type 2 diabetes: R esults of a quantitative survey
Authors:
Open Access
- 12 September 2017
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 20 (2) , 301-308
Abstract
Basal insulin (BI) treatment initiation and dose titration in type 2 diabetes (T2DM) are often delayed. Such “clinical inertia” results in poor glycemic control and high risk of long-term complications. This survey aimed to determine healthcare professional (HCP) and patient attitudes to BI initiation and titration. An online survey (July–August 2015) including HCPs and patients with T2DM in the USA, France and Germany. Patients were ≥18 years old and had been on BI for 6–36 months, or discontinued BI within the previous 12 months. Participants comprised 386 HCPs and 318 people with T2DM. While >75% of HCPs reported discussing titration at the initiation visit, only 16–28% of patients remembered such discussions, many (32–42%) were unaware of the need to titrate BI, and only 28–39% recalled mention of the time needed to reach glycemic goals. Most HCPs and patients agreed that more effective support tools to assist BI initiation/titration are needed; patients indicated that provision of such tools would increase confidence in self-titration. HCPs identified fear of hypoglycemia, failure to titrate in the absence of symptoms, and low patient motivation as important titration barriers. In contrast, patients identified weight gain, the perception that titration meant worsening disease, frustration over the time to reach HbA1c goals and fear of hypoglycemia as major factors. A disconnect exists between HCP- and patient-perceived barriers to effective BI titration. To optimize titration, strategies should be targeted to improve HCP–patient communication, and provide support and educational tools.Keywords
Funding Information
- Sanofi
This publication has 27 references indexed in Scilit:
- 2013 ESC guidelines on the management of stable coronary artery diseaseEuropean Heart Journal, 2013
- Barriers to Insulin Progression Among Patients With Type 2 DiabetesThe Diabetes Educator, 2012
- Assessing achievement and maintenance of glycemic control by patients initiating basal insulinCurrent Medical Research and Opinion, 2012
- The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesDiabetes, Obesity and Metabolism, 2012
- Literacy and Retention of Information After a Multimedia Diabetes Education Program and Teach-BackJournal of Health Communication, 2011
- Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetesCurrent Medical Research and Opinion, 2011
- Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) studyDiabetes Research and Clinical Practice, 2011
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated HemoglobinThe Annals of Family Medicine, 2007
- Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic ControlJournal of General Internal Medicine, 2007